These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1098848)

  • 1. Thioridazine plasma levels and clinical response.
    Gottschalk LA; Biener R; Noble EP; Birch H; Wilbert DE; Heiser JF
    Compr Psychiatry; 1975; 16(4):323-37. PubMed ID: 1098848
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
    Vanderheeren FA; Muusze RG
    Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
    Muusze RG; Vanderheeren FA
    Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma levels and clinical effects of thioridazine and thiothixene.
    Bergling R; Mjorndal T; Oreland L; Rapp W; Wold S
    J Clin Pharmacol; 1975; 15(2-3):178-86. PubMed ID: 1091665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effect and plasma level of thioridazine.
    de Jonghe FE; van der Helm HJ; Schalken HF; Thiel JH
    Acta Psychiatr Scand; 1973; 49(5):535-45. PubMed ID: 4586599
    [No Abstract]   [Full Text] [Related]  

  • 6. Plasma and red cell levels of thioridazine and clinical response in schizophrenia.
    Smith RC; Baumgartner R; Ravichandran GK; Shvartsburd A; Schoolar JC; Allen P; Johnson R
    Psychiatry Res; 1984 Aug; 12(4):287-96. PubMed ID: 6594712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blood levels of thioridazine and some of its metabolites in psychiatric patients. A preliminary report.
    Buyze G; Egberts PF; Muusze RG; Poslavsky A
    Psychiatr Neurol Neurochir; 1973; 76(3):229-39. PubMed ID: 4725794
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined therapy with thioridazine decreases plasma levels of quetiapine inTaiwanese schizophrenic patients.
    Chang SC; Lu ML; Wang YC; Lin FW; Huang SH; Kuo PH; Ho HO; Wu TH
    Ther Drug Monit; 2012 Jun; 34(3):345-8. PubMed ID: 22569350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect and plasma level of thioridazine in schizophrenic patients (author's transl)].
    Klein HE; Chandra O; Matussek N
    Pharmakopsychiatr Neuropsychopharmakol; 1975 May; 8(3):122-31. PubMed ID: 1233515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 11. Further studies on the mechanism of antipsychotic action: potentiation by alpha-methyltyrosine of thioridazine effects in chronic schizophrenics.
    Carlsson A; Roos BE; Wålinder J; Skott A
    J Neural Transm; 1973; 34(2):125-32. PubMed ID: 4146641
    [No Abstract]   [Full Text] [Related]  

  • 12. Behavioral effects of drug therapy on psychogeriatric inpatients. I. Chlorpromazine and thioridazine.
    Altman H; Mehta D; Evenson RC; Sletten IW
    J Am Geriatr Soc; 1973 Jun; 21(6):241-8. PubMed ID: 4575803
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of thioridazine tablets to chlorpromazine spansules in the maintenance care of chronic schizophrenics.
    Bartlett C
    Curr Ther Res Clin Exp; 1971 Feb; 13(2):100-6. PubMed ID: 4994211
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 15. Itil TM, Keskiner A, Fink M: Thioridazine and chlordiazepoxide, alone and combined, in the treatment of chronic schizophrenia.
    Holden JM
    Compr Psychiatry; 1968 Nov; 9(6):633-43. PubMed ID: 4883430
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychophysiological and behavioral effects of phenothiazine administration in acute schizophrenics as a function of premorbid status.
    LaPolla A; Goldstein MJ; Judd LL; Rodnick EH
    J Psychiatr Res; 1969 May; 6(4):271-87. PubMed ID: 4892691
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory changes with chlordiazepoxide and thioridazine, alone and combined.
    Holden JM; Itil TM
    Can Psychiatr Assoc J; 1969 Jun; 14(3):299-301. PubMed ID: 4890979
    [No Abstract]   [Full Text] [Related]  

  • 18. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation by metyrosine of thioridazine effects in chronic schizophrenics. A long-term trial using double-blind crossover technique.
    Wålinder J; Skott A; Carlsson A; Roos BE
    Arch Gen Psychiatry; 1976 Apr; 33(4):501-5. PubMed ID: 779704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent pharmacotherapy in chronic schizophrenia.
    Prien RF; Gillis RD; Caffey EM
    Hosp Community Psychiatry; 1973 May; 24(5):317-22. PubMed ID: 4574574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.